Cloud Banner

Healthcare

Image

Global Limulus Amebocyte Lysate (LAL) Testing Market – Industry Trends and Forecast to 2030

  • Healthcare
  • Upcoming Report
  • Sep 2023
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Limulus Amebocyte Lysate (LAL) Testing Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR - 9% Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 193.54 Million
Diagram Market Size (Forecast Year) USD 377.03 Million
Diagram CAGR 9%

Global Limulus Amebocyte Lysate (LAL) Testing Market, By Testing Methods (Gel Clot Endotoxin Test, Chromogenic Endotoxin Test, Turbidimetric Endotoxin Test), Application (Medical Device Manufacturing, Pharmaceutical Manufacturing) – Industry Trends and Forecast to 2030.

Limulus Amebocyte Lysate (LAL) Testing Market Analysis and Size

An aqueous extract of blood cells (amoebocytes) from the Limulus polyphemus, an Atlantic horseshoe crab, is called Limulus amebocyte lysate (LAL). LAL reagents are generally used to check for endotoxins in biological products, medical devices, and injectable medicines. They also have a variety of other uses, including in renal dialysis facilities. The limulus amoebocyte lysate (LAL) test with chromogenic substrate is faster than the gelation method, and it can be automated.

Data Bridge Market Research analyses that the limulus amebocyte lysate (LAL) testing market which was USD 193.54 million in 2022, would rocket up to USD 377.03 million by 2030, and is expected to undergo a CAGR of 9.00% during the forecast period. This indicates that the market value. “Gel Clot Endotoxin Test” dominates the testing methods segment of the global limulus amebocyte lysate (LAL) testing market owing to rise in incidence of chronic diseases. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Limulus Amebocyte Lysate (LAL) Testing Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015-2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

By Testing Methods (Gel Clot Endotoxin Test, Chromogenic Endotoxin Test, Turbidimetric Endotoxin Test), Application (Medical Device Manufacturing, Pharmaceutical Manufacturing)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Market Players Covered

Pacific BioLabs (U.S.), Lonza (Switzerland), Nelson Laboratories, LLC (U.S.), Bio-Synthesis Inc (U.S.), Biogenuix (India), GenScript (U.S.), Thermo Fisher Scientific, Inc, (U.S.), SGS SA (Switzerland), WuXi AppTec (China), Sartorius AG (Germany), AstraZeneca (U.K.), Novasep (France), Merck KGaA (Germany), Charles River Laboratories (U.K.), among others

Market Opportunities

  • Increasing pharmaceutical outsourcing
  • Expansion of biotechnology and bio manufacturing industries
  • Adoption of rapid endotoxin testing methods

Market Definition

The LAL (limulus amebocyte lysate) testing, also known as bacterial endotoxin testing, is a crucial component of pharmaceutical microbiology and is used to determine the presence and concentration of bacterial endotoxins in medicines and biological products. Lipopolysaccharides called endotoxins, a subclass of pyrogen, are found in the cell walls of gram-negative bacteria. Pyrogens are a group of compounds that raise the body temperature and can be dangerous or even lethal if delivered to people above a particular dose.

Limulus Amebocyte Lysate (LAL) Testing Market Dynamics

Drivers

  • Increasing Focus on Product Quality and Patient Safety

Ensuring product quality and patient safety is a paramount concern in the healthcare industry. Endotoxin contamination poses risks to patient health and can lead to severe complications. The implementation of LAL testing as a quality control measure helps in identifying and preventing endotoxin-related issues, driving market growth

  • Rising Demand for Biopharmaceuticals

The growing demand for biopharmaceutical products, such as monoclonal antibodies, recombinant proteins, and cell-based therapies, necessitates rigorous endotoxin testing. LAL testing plays a crucial role in ensuring the safety and efficacy of biopharmaceuticals, driving market expansion

  • Technological Advancements in LAL Testing

Continuous advancements in LAL testing methodologies and instrumentation have improved test sensitivity, accuracy, and efficiency. Innovations, such as chromogenic LAL assays and automated testing systems, have facilitated faster and more reliable endotoxin testing, contributing to market growth

Opportunities

  • Increasing Pharmaceutical Outsourcing

The growing trend of pharmaceutical outsourcing, including contract manufacturing and contract testing services, presents opportunities for the market. Outsourcing enables companies to access specialized expertise and infrastructure for endotoxin testing, driving market growth

  • Expansion of Biotechnology and Bio Manufacturing Industries

The expansion of the biotechnology and bio manufacturing industries creates opportunities for the market. The increasing production of biologics, cell therapies, and gene therapies necessitates extensive endotoxin testing, driving market expansion

Restraints/Challenges

  • Limited Availability of Horseshoe Crabs

The limited availability of horseshoe crabs, which are the source of LAL, poses a challenge to the market. Strict regulations and ethical considerations related to the harvesting of horseshoe crabs for LAL production may affect the supply chain and drive up costs

  • Standardization of Testing Methods

Ensuring standardization of LAL testing methods and harmonization of testing practices across different regions and industries is a challenge. Variability in testing protocols, reagents, and assay formats may lead to inconsistencies in endotoxin test results, creating challenges for comparability and regulatory compliance

This global limulus amebocyte lysate (LAL) testing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global limulus amebocyte lysate (LAL) testing market Contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth

Recent Development

  • In July 2020, Lonza Sales AG and Sanquin Reagents BV announced a strategic partnership to commercialize a collection of specialized reagents for the monocyte activation test-based pyrogen testing of parenteral pharmaceuticals and medical devices (MAT)

Global Limulus Amebocyte Lysate (LAL) Testing Market Scope

The global limulus amebocyte lysate (LAL) testing market is segmented on the basis of application and testing method. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Testing Method

  • Gel Clot Endotoxin Test
  • Chromogenic Endotoxin Test
  • Turbidimetric Endotoxin Test

Application                                                

  • Medical Device Manufacturing
  • Pharmaceutical Manufacturing

Global Limulus Amebocyte Lysate (LAL) Testing Market Regional Analysis/Insights

The global limulus amebocyte lysate (LAL) testing market is analysed and market size insights and trends are provided by country, application and testing method as referenced above.

The countries covered in the  limulus amebocyte lysate (LAL) testing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the global limulus amebocyte lysate (LAL) testing market due to the increasing government initiatives to promote research activities related to infectious diseases.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 owing to factors such as improving healthcare infrastructure, rising awareness about novel diagnostic techniques.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and up-stream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The global limulus amebocyte lysate (LAL) testing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global limulus amebocyte lysate (LAL) testing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global limulus amebocyte lysate (LAL) testing market. The data is available for historic period 2010 to 2020.

Competitive Landscape and Limulus Amebocyte Lysate (LAL) Testing Market Share Analysis

The global limulus amebocyte lysate (LAL) testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companie’s focus related to global limulus amebocyte lysate (LAL) testing market.

Some of the major players operating in the global limulus amebocyte lysate (LAL) testing market are

  • Pacific BioLabs (U.S.)
  • Lonza (Switzerland)
  • Nelson Laboratories, LLC (U.S.)
  • Bio-Synthesis Inc (U.S.)
  • Biogenuix (India)
  • GenScript (U.S.)
  • Thermo Fisher Scientific, Inc, (U.S.)
  • SGS SA (Switzerland)
  • WuXi AppTec (China)
  • Sartorius AG (Germany)
  • AstraZeneca (U.K.)
  • Novasep (France)
  • Merck KGaA (Germany)
  • Charles River Laboratories (U.K.)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The limulus amebocyte lysate (LAL) testing market size will be worth USD 377.03 million by 2030.
The growth rate of the limulus amebocyte lysate (LAL) testing market is 9.00% by 2030.
Increasing Focus on Product Quality and Patient Safety, Rising Demand for Biopharmaceuticals & Technological Advancements in LAL Testing are the growth drivers of the limulus amebocyte lysate (LAL) testing market.
Application and testing method are the factors on which the limulus amebocyte lysate (LAL) testing market research is based.
Major companies in the limulus amebocyte lysate (LAL) testing market are Pacific BioLabs (U.S.), Lonza (Switzerland), Nelson Laboratories, LLC (U.S.), Bio-Synthesis Inc (U.S.), Biogenuix (India), GenScript (U.S.), Thermo Fisher Scientific, Inc, (U.S.), SGS SA (Switzerland), WuXi AppTec (China), Sartorius AG (Germany), AstraZeneca (U.K.), Novasep (France), Merck KGaA (Germany), Charles River Laboratories (U.K.), among others
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials